41.87% | % of shares held by all insiders |
29.55% | % of shares held by institutions |
50.83% | % of float held by institutions |
56 | Number of institutions holding shares |
Holder | Shares | Date reported | % out | Value |
---|---|---|---|---|
BVF Inc. | 14,571,236 | 31 Mar 2024 | 14.73% | 54,059,286 |
Avidity Partners Management, LP | 4,470,000 | 31 Mar 2024 | 4.52% | 16,583,700 |
Blackrock Inc. | 2,541,952 | 31 Mar 2024 | 2.57% | 9,430,642 |
Redmile Group, LLC | 2,007,031 | 31 Mar 2024 | 2.03% | 7,446,085 |
Morgan Stanley | 1,383,854 | 31 Mar 2024 | 1.40% | 5,134,098 |
Wells Fargo & Company | 1,119,703 | 31 Mar 2024 | 1.13% | 4,154,098 |
Platinum Investment Management Ltd | 1,095,026 | 31 Mar 2024 | 1.11% | 4,062,546 |
Renaissance Technologies, LLC | 515,779 | 31 Mar 2024 | 0.52% | 1,913,540 |
Deutsche Bank Aktiengesellschaft | 253,375 | 31 Mar 2024 | 0.26% | 940,021 |
Handelsbanken Fonder AB | 150,000 | 31 Mar 2024 | 0.15% | 556,500 |
Holder | Shares | Date reported | % out | Value |
---|---|---|---|---|
Blackrock Funds-Health Sciences Opportunity Portfolio | 1,083,340 | 29 Feb 2024 | 1.10% | 4,019,191 |
BlackRock Health Sciences Term Trust | 752,390 | 31 Mar 2024 | 0.76% | 2,791,366 |
iShares Biotechnology ETF | 424,408 | 30 Apr 2024 | 0.43% | 1,574,553 |
Blackrock Health Sciences Trust | 78,180 | 31 Mar 2024 | 0.08% | 290,047 |
Fidelity NASDAQ Composite Index Fund | 54,797 | 30 Apr 2024 | 0.06% | 203,296 |
Pacific Select Fund-Health Sciences Portfolio | 53,150 | 31 Mar 2024 | 0.05% | 197,186 |
Fidelity Select Portfolios - Biotechnology | 27,202 | 30 Apr 2024 | 0.03% | 100,919 |
DFA U.S. Vector Equity Portfolio | 15,821 | 31 Jan 2024 | 0.02% | 58,695 |
DFA U.S. Micro Cap Series | 10,530 | 31 Jan 2024 | 0.01% | 39,066 |
DFA U.S. Core Equity 2 Portfolio | 8,197 | 31 Jan 2024 | 0.01% | 30,410 |